SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-003564
Filing Date
2020-06-12
Accepted
2020-06-12 15:23:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a2241865z424b5.htm 424B5 207154
2 G985367.JPG g985367.jpg GRAPHIC 9070
3 G561532.JPG g561532.jpg GRAPHIC 12689
4 G306206.JPG g306206.jpg GRAPHIC 11586
  Complete submission text file 0001047469-20-003564.txt   254663
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235399 | Film No.: 20960035
SIC: 2835 In Vitro & In Vivo Diagnostic Substances